These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10629390)

  • 1. Clinical aspects and laboratory problems in hereditary thrombophilia.
    Samama M; Gerotziafas G; Conard J; Horellou M; Elalamy I
    Haemostasis; 1999; 29(2-3):76-99. PubMed ID: 10629390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coagulation factor mutations and thrombosis].
    Aiach M; Alhenc-Gelas M; Borgel D; Emmerich J; Gandrille S; Picard V
    Med Sci (Paris); 2006 Nov; 22(11):985-9. PubMed ID: 17101102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary thrombophilia in ethnic Omani patients.
    Pathare A; Al Kindi S; Al Haddabi H; Dennison D; Bayoumi R; Muralitharan S
    Am J Hematol; 2006 Feb; 81(2):101-6. PubMed ID: 16432849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
    Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
    Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
    Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
    J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertain thrombophilia markers.
    Franchini M; Martinelli I; Mannucci PM
    Thromb Haemost; 2016 Jan; 115(1):25-30. PubMed ID: 26271270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
    Heylen E; Miljic P; Willemse J; Djordjevic V; Radojkovic D; Colovic M; Elezovic I; Hendriks D
    Thromb Res; 2009 Sep; 124(4):427-32. PubMed ID: 19195685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic algorithm for thrombophilia screening.
    Margetic S
    Clin Chem Lab Med; 2010 Dec; 48 Suppl 1():S27-39. PubMed ID: 21054193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
    Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
    Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.
    Bombeli T; Basic A; Fehr J
    Am J Hematol; 2002 Jun; 70(2):126-32. PubMed ID: 12111785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of high-risk thrombophilia with an automated, global test: the Coagulation Inhibitor Potential assay.
    Réger B; Losonczy H; Nagy Á; Péterfalvi Á; Mózes R; Pótó L; Farkas N; Kovács GL; Miseta A; Hussain A; Tóth O
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):435-441. PubMed ID: 29782332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of screening on thrombophilia for patients with venous thrombosis.
    Paschôa AF; Guillaumon AT
    Int Angiol; 2006 Mar; 25(1):52-9. PubMed ID: 16520725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
    Orlando C; Heylen O; Lissens W; Jochmans K
    Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.